How to use ibrutinib

The emergence of new targeted drugs, affecting B-cell receptor signaling pathway opens a new page in the treatment of chronic lymphocytic leukemia (CLL). It is not simply expanding choice, it will likely to change total strategy of CLL management. Clinical trials have shown improvement of overall su...

Full description

Saved in:
Bibliographic Details
Main Authors: Е. А. Nikitin, V. I. Vorobiev, М. А. Panteleev, G. E. Gendlin, V. V. Ptushkin
Format: Article
Language:Russian
Published: ABV-press 2017-04-01
Series:Онкогематология
Subjects:
Online Access:https://oncohematology.abvpress.ru/ongm/article/view/229
Tags: Add Tag
No Tags, Be the first to tag this record!